Correlation Between Stoke Therapeutics and Alzamend Neuro
Can any of the company-specific risk be diversified away by investing in both Stoke Therapeutics and Alzamend Neuro at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stoke Therapeutics and Alzamend Neuro into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Stoke Therapeutics and Alzamend Neuro, you can compare the effects of market volatilities on Stoke Therapeutics and Alzamend Neuro and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stoke Therapeutics with a short position of Alzamend Neuro. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stoke Therapeutics and Alzamend Neuro.
Diversification Opportunities for Stoke Therapeutics and Alzamend Neuro
0.69 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Stoke and Alzamend is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Stoke Therapeutics and Alzamend Neuro in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alzamend Neuro and Stoke Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stoke Therapeutics are associated (or correlated) with Alzamend Neuro. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alzamend Neuro has no effect on the direction of Stoke Therapeutics i.e., Stoke Therapeutics and Alzamend Neuro go up and down completely randomly.
Pair Corralation between Stoke Therapeutics and Alzamend Neuro
Given the investment horizon of 90 days Stoke Therapeutics is expected to generate 0.92 times more return on investment than Alzamend Neuro. However, Stoke Therapeutics is 1.09 times less risky than Alzamend Neuro. It trades about -0.01 of its potential returns per unit of risk. Alzamend Neuro is currently generating about -0.21 per unit of risk. If you would invest 1,236 in Stoke Therapeutics on September 1, 2024 and sell it today you would lose (25.00) from holding Stoke Therapeutics or give up 2.02% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Stoke Therapeutics vs. Alzamend Neuro
Performance |
| Timeline |
| Stoke Therapeutics |
| Alzamend Neuro |
Stoke Therapeutics and Alzamend Neuro Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Stoke Therapeutics and Alzamend Neuro
The main advantage of trading using opposite Stoke Therapeutics and Alzamend Neuro positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stoke Therapeutics position performs unexpectedly, Alzamend Neuro can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alzamend Neuro will offset losses from the drop in Alzamend Neuro's long position.| Stoke Therapeutics vs. Adaptimmune Therapeutics Plc | Stoke Therapeutics vs. Black Diamond Therapeutics | Stoke Therapeutics vs. Relay Therapeutics | Stoke Therapeutics vs. Pliant Therapeutics |
| Alzamend Neuro vs. Tff Pharmaceuticals | Alzamend Neuro vs. Eliem Therapeutics | Alzamend Neuro vs. Inhibrx | Alzamend Neuro vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |